__NUXT_JSONP__("/drugs/Tovetumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:b,chebiId:b,chemicalFormula:b,definition:"A humanized monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. Tovetumab inhibits activation of the cell-surface tyrosine kinase PDGFR alpha subunit and subsequent triggering of mitogenic signaling pathways, including the JAK\u002FSTAT, PI3K\u002FAkt, and MAP kinase pathways. PDGFR alpha acts as a mitogenic signaling receptor for cells of mesenchymal origin and inhibition of receptor activity may inhibit tumor cell proliferation.",fdaUniiCode:"2XY62K75UV",identifier:"C82684",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C164036"],synonyms:["Anti-PDGFR Alpha Monoclonal Antibody MEDI-575","Anti-Platelet-Derived Growth Factor Receptor Alpha Monoclonal Antibody MEDI-575","MEDI-575","TOVETUMAB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTovetumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Tovetumab","","2021-10-30T13:46:05.563Z")));